TScan Therapeutics (TCRX) Stock Chart & Stock Price History $1.67 -0.02 (-1.18%) As of 01:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TScan Therapeutics Stock Price Performance The TScan Therapeutics (TCRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 70.91%, with a year-to-date return of -45.07%. In the past month, the stock has decreased 7.22%, reflecting recent market activity. As of the latest close, TScan Therapeutics traded at $1.69 with a market cap of $95.91 million and volume of 308,136 shares. Receive TCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-9.73%1 Month Performance-7.22%3 Month Performance+9.15%Year-To-Date Performance-45.07%1 Year Performance-70.91% TCRX Stock Chart for Tuesday, September, 16, 2025 TCRX Chart by TradingView TScan Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/15/2025$1.76$1.69-3.98%$1.78$1.66308,136 shs$95.91 million09/12/2025$1.85$1.76-4.86%$1.85$1.72229,432 shs$99.88 million09/11/2025$1.84$1.85+0.54%$1.86$1.76307,483 shs$104.98 million09/10/2025$1.84$1.84$1.88$1.78407,197 shs$104.42 million09/09/2025$1.88$1.84-2.13%$1.92$1.81196,143 shs$104.42 million09/08/2025$1.91$1.88-1.57%$1.95$1.83129,987 shs$106.69 million09/05/2025$1.89$1.91+1.06%$1.96$1.86270,203 shs$108.39 million09/04/2025$1.87$1.89+1.07%$1.90$1.81124,491 shs$107.26 million09/03/2025$1.75$1.87+6.86%$1.87$1.73278,613 shs$106.12 million09/02/2025$1.80$1.75-2.78%$1.85$1.74147,227 shs$99.31 million Get the Latest News and Ratings for TCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/01/2025$1.80$1.80$1.86$1.7991,404 shs$102.15 million08/29/2025$1.82$1.80-1.10%$1.86$1.7991,404 shs$102.15 million08/28/2025$1.87$1.82-2.67%$1.92$1.81145,675 shs$103.29 million08/27/2025$1.89$1.87-1.06%$1.95$1.87115,250 shs$106.12 million08/26/2025$1.90$1.89-0.53%$1.93$1.77407,007 shs$107.25 million08/25/2025$1.87$1.90+1.60%$1.93$1.80160,731 shs$107.83 million08/22/2025$1.74$1.87+7.47%$1.89$1.75353,254 shs$105.82 million08/21/2025$1.70$1.74+2.35%$1.81$1.66240,730 shs$98.47 million08/20/2025$1.68$1.70+1.19%$1.75$1.63160,275 shs$96.21 million08/19/2025$1.79$1.68-6.15%$1.84$1.64250,517 shs$95.07 million08/18/2025$1.80$1.79-0.56%$1.84$1.76103,935 shs$101.30 million08/15/2025$1.81$1.80-0.55%$1.86$1.79189,470 shs$101.86 million Related Companies Solid Biosciences Stock Chart Astria Therapeutics Stock Chart Nanobiotix Stock Chart Fulcrum Therapeutics Stock Chart Cullinan Therapeutics Stock Chart Kamada Stock Chart Inhibrx Biosciences Stock Chart Aura Biosciences Stock Chart ADC Therapeutics Stock Chart PureTech Health Stock Chart Receive TCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCRX) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TScan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TCRX Stock Alerts